Ketamine Terminated Phase 2 Trials for Alcohol Dependence / Major Depressive Disorder (MDD) / Magnetic Resonance Imaging (MRI) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01957410A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
NCT02122562The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder
NCT01135758Study of Depression-Ketamine-Brain Function